Low-dose lung cancer screening: Nodule measurement and management

Joan E. Walter; Marjolein A. Heuvelmans; Monique Dorrius; Matthijs Oudkerk

doi:10.21037/pcm.2019.07.03

Low-dose lung cancer screening: Nodule measurement and management

Joan E. Walter
, Marjolein A. Heuvelmans
, Monique Dorrius
, Matthijs Oudkerk^*

^*Corresponding author for this work

University of Groningen
Institute for Diagnostic Accuracy

Research output: Contribution to journal › Review article › Academic › peer-review

6 Downloads (Pure)

Abstract

Lung cancer screening by low-dose computed tomography (LDCT) is recommended for high-risk individuals by US guidelines, while lung cancer programs in Europe and Asia are being prepared. This review will mainly focus on two most recent concepts and discusses the latest developments. First, while a pulmonary nodule has an infinite number of diameters, it possesses only one volume. Traditionally, nodule size has been determined by diameter measurement, however semi-automated measurement of nodule volume is becoming increasingly available. Secondly, nodules that develop newly after baseline should distinguished from nodules already present at baseline. Until recently, new nodule management was mostly based on expert-opinion or data derived from baseline nodules.

Original language	English
Article number	24
Journal	Precision Cancer Medicine
Volume	2
Issue number	August
DOIs	https://doi.org/10.21037/pcm.2019.07.03
Publication status	Published - 1 Aug 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.21037/pcm.2019.07.03

Low-dose-lung-cancer-screening.pdfFinal published version, 391 KBLicence: Taverne

Cite this

@article{f4e1a009bb6f4f0ca5de15cda9c1ac4d,

title = "Low-dose lung cancer screening: Nodule measurement and management",

abstract = "Lung cancer screening by low-dose computed tomography (LDCT) is recommended for high-risk individuals by US guidelines, while lung cancer programs in Europe and Asia are being prepared. This review will mainly focus on two most recent concepts and discusses the latest developments. First, while a pulmonary nodule has an infinite number of diameters, it possesses only one volume. Traditionally, nodule size has been determined by diameter measurement, however semi-automated measurement of nodule volume is becoming increasingly available. Secondly, nodules that develop newly after baseline should distinguished from nodules already present at baseline. Until recently, new nodule management was mostly based on expert-opinion or data derived from baseline nodules.",

author = "Walter, \{Joan E.\} and Heuvelmans, \{Marjolein A.\} and Monique Dorrius and Matthijs Oudkerk",

year = "2019",

month = aug,

day = "1",

doi = "10.21037/pcm.2019.07.03",

language = "English",

volume = "2",

journal = "Precision Cancer Medicine",

issn = "2617-2216",

publisher = "AME Publishing Company",

number = "August",

}

TY - JOUR

T1 - Low-dose lung cancer screening

T2 - Nodule measurement and management

AU - Walter, Joan E.

AU - Heuvelmans, Marjolein A.

AU - Dorrius, Monique

AU - Oudkerk, Matthijs

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Lung cancer screening by low-dose computed tomography (LDCT) is recommended for high-risk individuals by US guidelines, while lung cancer programs in Europe and Asia are being prepared. This review will mainly focus on two most recent concepts and discusses the latest developments. First, while a pulmonary nodule has an infinite number of diameters, it possesses only one volume. Traditionally, nodule size has been determined by diameter measurement, however semi-automated measurement of nodule volume is becoming increasingly available. Secondly, nodules that develop newly after baseline should distinguished from nodules already present at baseline. Until recently, new nodule management was mostly based on expert-opinion or data derived from baseline nodules.

AB - Lung cancer screening by low-dose computed tomography (LDCT) is recommended for high-risk individuals by US guidelines, while lung cancer programs in Europe and Asia are being prepared. This review will mainly focus on two most recent concepts and discusses the latest developments. First, while a pulmonary nodule has an infinite number of diameters, it possesses only one volume. Traditionally, nodule size has been determined by diameter measurement, however semi-automated measurement of nodule volume is becoming increasingly available. Secondly, nodules that develop newly after baseline should distinguished from nodules already present at baseline. Until recently, new nodule management was mostly based on expert-opinion or data derived from baseline nodules.

UR - https://www.scopus.com/pages/publications/85110592844

U2 - 10.21037/pcm.2019.07.03

DO - 10.21037/pcm.2019.07.03

M3 - Review article

SN - 2617-2216

VL - 2

JO - Precision Cancer Medicine

JF - Precision Cancer Medicine

IS - August

M1 - 24

ER -

Low-dose lung cancer screening: Nodule measurement and management

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this